Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Opioid is a type of narcotic pain medication which is used to treat moderate to severe pain, such as, anesthesia, cough suppression, diarrhea suppression, surgical pain, injury or trauma, cancer pain, and pain arising from disease. The global opioids market is estimated to account for US$ 51,005.8 Mn in terms of value by the end of 2027.
Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/1017
Global Opioids Market: Drivers
High efficacy of synthetic opioids such as methadone and fentanyl is expected to boost growth of the global opioids market. These synthetically manufactured opioids are used to suppress the chances of getting addicted to natural opioids and resistant to natural opioids.
Global Opioids Market: Opportunities
Increasing R&D in synthesis of hybrids targeting opioid and neurokinin receptors is expected to offer lucrative growth opportunities to market players. For instance, in December 2019, researchers from the Medical University of Lodz reported the synthesis, structure–activity relationship, and pharmacological characterization of a series of hybrids combining opioid pharmacophores with either substance P (SP) fragments or neurokinin receptor (NK1) antagonist fragments in order to comprehend the role of the neurokinin system in opioid-induced antinociception.
Global Opioids Market: Restraints
However, the increasing cases of counterfeit opioids is expected to hamper growth of the global opioids market. For instance, in June 2019, the Drug Enforcement Administration warned regarding sale of counterfeit fentanyl pills and other synthetic opioids.
Browse Press Release: https://www.coherentmarketinsights.com/press-release/global-opioids-market-to-surpass-us-426-billion-threshold-by-2024-442
Key Takeaways:
The Morphine segment in the global opioids market was valued at US$ 13,697.6 Mn in 2018 and is expected to reach US$ 17,766.2 Mn by 2027 at a CAGR of 2.9% during the forecast period. The growth of the segment is attributed to increasing demand for treatment of acute and chronic pain during the forecast period. The Analgesia segment held dominant position in the global opioids market in 2018, accounting for 67.3% share in terms of volume, followed by cough suppression and diarrhea suppression segments, respectively. The growth of the segment is attributed to increasing research and development of new drugs.
Market Trends
Key players in the market are focused on product approvals and launches to expand their product portfolio. For instance, in June 2018, AcelRx Pharmaceuticals, Inc. received the European Commission (EC) approval for DZUVEO for management of acute, moderate to severe pain in adults in medically monitored settings. The market is witnessing increasing M&A activities. For instance, Grünenthal acquired the US-based pharmaceutical company Averitas Pharma in order to expand its presence in the U.S.
Regulations
- The European Society for Medical Oncology (ESMO) and the European Association for Palliative Care (EAPC) regulates the commercial use of opioids in cancer pain management across Europe
- The European Union conducts Access to Opioids Medication in Europe (ATOME) program, which ensures the availability of opioids across 12 European countries
- The U.K.’s Department of Health published “Drug Misuse and Dependence – Guidelines on Clinical Management” (DOH, 1999), which regulates the prescription and sales of opioid drugs in the country
Global Opioids Market: Competitive Landscape
Major players operating in the global opioids market include Pfizer, Inc., Boehringer Ingelheim, Janssen Pharmaceuticals, Inc., Actavis Plc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Endo Pharmaceuticals Inc., and Zyla Life Sciences.
Apply Promo Code “STAYHOME” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1017
Global Opioids Market: Key Developments
In October 2019, AmerisourceBergen, Cardinal Health, McKesson Corporation, Johnson & Johnson, and Teva Pharmaceuticals agreed to pay US$ 50 billion in cash to resolve opioid cases in U.S. In March 2019, Purdue Pharma reached a US$ 270 million settlement in a lawsuit which claimed its opioids contributed to the deaths of thousands of people.
Segmentation
Scope of the report
- Opioids Market, By Product Type:
- Morphine
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Opioids Market, By Application:
- Analgesia
- Cough Suppression
- Diarrhea Suppression
- Opioids Market, By Region:
- North America
- By Product Type:
- Morphine
- Codeine
- Fentanyl
- Meperidine
- Methadone
- By Application
- Analgesia
- Cough Suppression
- Diarrhea Suppression
- By Country:
- U.S.
- Canada
- By Product Type:
- Latin America
- By Product Type:
- Morphine
- Codeine
- Fentanyl
- Meperidine
- Methadone
- By Application
- Analgesia
- Cough Suppression
- Diarrhea Suppression
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Product Type:
- Europe
- By Product Type:
- Morphine
- Codeine
- Fentanyl
- Meperidine
- Methadone
- By Application
- Analgesia
- Cough Suppression
- Diarrhea Suppression
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- By Product Type:
- Asia Pacific
- By Product Type:
- Morphine
- Codeine
- Fentanyl
- Meperidine
- Methadone
- By Application
- Analgesia
- Cough Suppression
- Diarrhea Suppression
- By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Product Type:
- Middle East
- By Product Type:
- Morphine
- Codeine
- Fentanyl
- Meperidine
- Methadone
- By Application
- Analgesia
- Cough Suppression
- Diarrhea Suppression
- By Country:
- GCC
- Israel
- Rest of Middle East
- By Product Type:
- Africa
- By Product Type:
- Morphine
- Codeine
- Fentanyl
- Meperidine
- Methadone
- By Application
- Analgesia
- Cough Suppression
- Diarrhea Suppression
- By Country:
- South Africa
- Central Africa
- North Africa
- By Product Type:
- North America
Other Related Reports:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
